fibrosi
final
stage
mani
lung
diseas
effect
treatment
plasminogen
activ
primari
inhibitor
tissuetyp
urokinasetyp
plasminogen
activ
tpa
upa
respect
play
critic
role
develop
fibrosi
studi
explor
therapeut
potenti
oral
effect
small
molecul
inhibitor
model
lung
fibrosi
induc
transform
growth
potent
ubiquit
profibrogen
cytokin
human
lung
fibroblast
cell
result
show
intranas
instil
adenoviru
express
constitut
activ
increas
express
induc
fibrosi
murin
lung
tissu
hand
treat
mice
mgkg
day
start
day
instil
restor
activ
upa
tpa
almost
complet
block
lung
fibrosi
shown
collagen
stain
western
blot
measur
hydroxyprolin
loss
bodi
weight
evid
treatment
condit
furthermor
show
induc
apoptosi
myofibroblast
naiv
human
lung
fibroblast
apoptosi
associ
activ
induct
inhibit
asmooth
muscl
actin
fibronectin
express
inhibit
fibrot
respons
occur
even
cell
pretreat
hour
togeth
result
suggest
rel
safe
potent
antifibrot
agent
therapeut
potenti
fibrot
lung
diseas
pulmonari
fibrosi
characterist
featur
final
stage
mani
lung
diseas
includ
idiopath
pulmonari
fibrosi
cystic
fibrosi
acut
respiratori
distress
syndrom
sever
acut
respiratori
syndrom
sarcoidosi
silicosi
asbestosi
enigmat
fatal
form
pulmonari
fibrosi
idiopath
pulmonari
fibrosi
ipf
despit
decad
intens
studi
effect
treatment
devast
lung
diseas
develop
poor
understand
complex
patholog
process
past
lung
fibrosi
specul
result
unremit
inflammatori
respons
exogen
insult
lead
activ
prolifer
fibroblast
eventu
culmin
progress
fibrosi
therefor
antiinflammatori
agent
alon
combin
cytotox
drug
use
clinic
standard
therapeut
regimen
treatment
lung
fibrot
diseas
howev
littl
evid
indic
agent
alter
natur
histori
diseas
improv
surviv
patient
although
therapeut
strategi
use
clinic
trial
includ
interferong
antitransform
growth
factorb
anticonnect
tissu
growth
factor
antibodi
efficaci
treatment
remain
unclear
plasminogen
activ
inhibitor
primari
inhibitor
urokinasetyp
tissuetyp
plasminogen
activ
upa
tpa
respect
play
critic
role
wound
heal
tissu
remodel
express
increas
mani
fibrot
diseas
includ
ipf
experiment
model
fibrosi
knockout
gene
administr
small
interf
rna
attenu
wherea
overexpress
protein
enhanc
fibrot
respons
induc
differ
stimuli
line
evid
suggest
play
essenti
role
develop
lung
fibrosi
nonetheless
mechan
wherebi
promot
fibrosi
still
poorli
understood
importantli
inhibitor
develop
treatment
lung
fibrot
diseas
studi
explor
therapeut
potenti
oral
effect
small
molecul
inhibitor
lung
fibrosi
use
human
lung
fibroblast
wellestablish
lung
fibrosi
model
induc
transform
growth
potent
ubiquit
profibrogen
cytokin
result
show
oral
administr
day
mice
challeng
almost
complet
block
lung
fibrosi
signific
effect
bodi
weight
show
induc
myo
fibroblast
apoptosi
suppress
fibrot
respons
human
lung
fibroblast
togeth
result
suggest
small
molecul
inhibitor
promis
therapeut
agent
lung
fibrot
diseas
male
mice
week
old
challeng
plaqueform
unit
adenoviru
express
constitut
activ
viru
vector
salin
intranas
instil
four
day
later
mice
treat
mgkg
dissolv
dmso
solvent
gavag
daili
day
mice
kill
day
instil
bronchoalveolar
lavag
perform
left
lung
fix
paraformaldehyd
rest
lung
tissu
frozen
immedi
liquid
nitrogen
anim
maintain
lightdark
cycl
c
specif
pathogen
free
facil
procedur
involv
anim
approv
institut
anim
care
use
committe
univers
alabama
birmingham
cell
normal
human
lung
fibroblast
american
type
cultur
collect
manassa
va
cultur
eagl
minimum
essenti
medium
formul
american
type
cultur
collect
describ
previous
confluenc
cell
treat
ngml
r
minneapoli
mn
variou
period
time
mm
hour
amount
total
activ
tgfb
protein
bronchoalveolar
lavag
fluid
balf
measur
use
elisa
kit
catalogu
number
ebiosci
san
diego
ca
accord
protocol
provid
manufactur
amount
antigen
balf
determin
use
elisa
kit
molecular
innov
novi
mi
describ
previous
total
rna
isol
lung
tissu
use
trizol
reagent
mrna
procollagen
procollagen
iii
assess
northern
blot
hybrid
describ
previous
deposit
collagen
lung
reveal
masson
trichrom
stain
quantifi
morphometr
techniqu
describ
previous
immunohistochem
stain
asmooth
muscl
actin
asma
murin
lung
tissu
stain
monoclon
antimous
asma
antibodi
catalogu
number
biocar
medic
concord
ca
semiquantifi
previous
describ
hydroxyprolin
content
lung
tissu
determin
describ
elsewher
calcul
accord
standard
curv
deriv
activ
tpaupa
determin
revers
zymographi
zymographi
respect
describ
previous
intens
band
semiquantifi
use
imag
j
softwar
nation
institut
health
websit
western
blot
analys
protein
abund
conduct
describ
previous
use
antibodi
collagen
catalogu
number
santa
cruz
biotechnolog
santa
cruz
ca
asmpaigf
molecular
innov
asma
catalogu
number
biocar
medic
fibronectin
catalogu
number
bd
bioscienc
franklin
lake
nj
bactin
protein
load
control
protein
band
semiquantifi
use
imag
j
softwar
apoptosi
analyz
flow
cytometri
techniqu
use
alexa
fluor
annexin
v
kit
invitrogen
carlsbad
ca
follow
protocol
provid
manufactur
figur
effect
intranas
instil
adenoviru
express
constitut
activ
transform
growth
express
plasminogen
activ
inhibitor
accumul
collagen
murin
lung
tissu
adenoviru
vector
salin
administ
murin
lung
intranas
instil
seven
day
instil
mice
kill
amount
total
activ
transform
growth
well
total
protein
b
bronchoalveolar
lavag
fluid
balf
determin
elisa
c
repres
northern
blot
imag
procollagen
procol
mrna
murin
lung
tissu
use
rna
load
control
quantit
data
radioact
northern
blot
instant
imag
packard
instrument
co
meriden
ct
e
trichrom
stain
collagen
murin
lung
tissu
arrow
indic
collagen
significantli
differ
salinetr
mice
p
n
activ
determin
apoon
homogen
assay
catalogu
number
promega
madison
wi
accord
protocol
provid
manufactur
fluoresc
measur
excitationemiss
wavelength
nm
result
normal
accord
protein
concentr
data
present
mean
sem
evalu
oneway
anova
statist
signific
determin
post
hoc
tukey
test
intranas
instil
increas
express
induc
lung
fibrosi
mice
potent
ubiquit
profibrogen
cytokin
increas
almost
fibrot
diseas
explor
therapeut
potenti
inhibitor
lung
fibrot
diseas
first
examin
whether
intranas
instil
noninvas
lung
drugdeliveri
techniqu
adenoviru
express
constitut
activ
would
effect
induc
express
lung
fibrosi
mice
result
show
concentr
protein
activ
latent
form
balf
dramat
increas
day
intranas
instil
figur
associ
increas
express
instil
significantli
increas
concentr
protein
mrna
balf
lung
tissu
figur
well
express
procollagen
mrna
deposit
collagen
lung
figur
viru
vector
alon
hand
exert
signific
effect
express
tgfb
neither
increas
deposit
collagen
lung
suggest
fibrot
respons
induc
adenoviru
importantli
fibrot
respons
induc
intranas
instil
persist
least
day
data
shown
result
suggest
intranas
instil
effect
reliabl
mean
induc
lung
fibrosi
express
tgfb
increas
almost
fibrot
diseas
tgfbinduc
lung
fibrosi
serv
good
anim
model
test
therapeut
potenti
antifibrot
drug
use
studi
effect
inhibitor
activ
tpaupa
lung
mice
treat
without
novel
oral
effect
inhibitor
shown
exert
potent
antithrombot
effect
rat
monkey
model
without
caus
overt
toxic
effect
bleed
time
test
antifibrot
potenti
first
examin
effect
oral
administr
activ
tpa
upa
murin
lung
tissu
result
show
administr
increas
activ
figur
suppress
activ
upa
although
exert
signific
effect
activ
tpa
figur
treatment
hand
inhibit
activ
figur
complet
revers
inhibitori
effect
upa
activ
figur
also
observ
activ
tpa
upa
mice
treat
plu
significantli
higher
treat
alon
result
suggest
express
tpa
upa
protein
may
increas
mice
even
though
activ
inhibit
simultan
increas
express
activ
obviou
bodi
weight
loss
evid
upon
treatment
data
shown
suggest
caus
obviou
toxic
condit
use
studi
effect
lung
fibrosi
explor
measur
deposit
collagen
hydroxyprolin
content
murin
lung
tissu
result
show
administr
significantli
reduc
accumul
collagen
lung
shown
trichrom
stain
western
blot
hydroxyprolin
measur
figur
immunohistochem
stain
western
blot
show
suppress
asmooth
muscl
actin
asma
marker
myofibroblast
differenti
murin
lung
figur
suggest
may
prevent
b
figur
effect
small
molecul
inhibitor
activ
tissuetyp
plasminogen
activ
tpa
urokinasetyp
plasminogen
activ
upa
lung
mice
intranas
instil
salin
activ
determin
revers
zymographi
b
activ
tpa
upa
determin
zymographi
photoneg
imag
gel
present
dark
band
attribut
inhibit
casein
degrad
revers
zymographi
protein
lytic
band
zymographi
semiquantifi
imag
j
softwar
semiquantifi
data
present
bottom
b
significantli
differ
salin
solventtr
control
mice
p
n
differenti
myofibroblast
induc
apoptosi
myofibroblast
interestingli
western
blot
analysi
show
almost
complet
block
induc
express
data
clearli
demonstr
potent
antifibrot
activ
model
lung
fibrosi
explor
therapeut
potenti
treatment
lung
fibrot
diseas
mechan
wherebi
block
induc
lung
fibrosi
assess
effect
fibrot
respons
human
lung
fibroblast
cell
use
vitro
studi
result
vivo
studi
indic
adenoviru
caus
fibrosi
murin
lung
tissu
figur
result
show
treatment
increas
activ
inhibit
activ
upa
wherea
treat
cell
block
activ
arbitrari
unit
cell
treat
solvent
plu
respect
stimul
activ
upa
arbitrari
unit
cell
treat
solvent
plu
respect
neither
alon
exert
signific
effect
activ
tpa
importantli
western
blot
analys
show
ad
cultur
medium
simultan
almost
complet
block
express
asma
fibronectin
figur
explor
whether
suppress
progress
fibrosi
initi
pretreat
cell
hour
mm
hour
result
show
express
asma
increas
earli
hour
treatment
figur
howev
significantli
reduc
express
asma
fibronectin
even
cell
pretreat
hour
figur
data
suggest
resolv
preexist
fibrosi
block
progress
fibrosi
although
tradit
view
support
previou
studi
suggest
promot
fibrosi
suppress
degrad
extracellular
matrix
ecm
emerg
evid
suggest
may
exert
profibrogen
effect
prevent
apoptosi
myo
fibroblast
therefor
examin
whether
induc
apoptosi
human
lung
fibroblast
result
indic
alon
exert
signific
effect
apoptosi
cell
wherea
significantli
increas
apoptot
cell
number
naiv
activ
fibroblast
figur
interestingli
cell
treat
therefor
underw
myofibroblast
differenti
seem
sensit
apoptosi
naiv
fibroblast
figur
apoptosi
induc
also
activ
figur
increas
express
tumor
repressor
initi
apoptosi
figur
togeth
data
suggest
block
fibrosi
probabl
induc
apoptosi
myo
fibroblast
fibrosi
final
stage
mani
diseas
involv
almost
organ
system
includ
lung
effect
treatment
avail
devast
diseas
play
key
role
develop
fibrosi
therefor
ideal
therapeut
target
treatment
fibrot
diseas
nonetheless
perform
intens
studi
inhibitor
develop
purpos
report
first
time
best
knowledg
oral
effect
novel
small
molecul
inhibitor
demonstr
potent
antithrombot
activ
low
toxic
sever
anim
speciesmodel
almost
complet
block
lung
fibrosi
anim
model
vitro
studi
show
induc
apoptosi
myo
fibroblast
significantli
reduc
fibrot
respons
even
cell
pretreat
hour
data
suggest
promis
antifibrot
agent
block
progress
fibrosi
mechan
wherebi
block
lung
fibrosi
unclear
present
administr
day
mice
challeng
although
monitor
fibrot
chang
day
instil
sime
colleagu
gener
adenoviru
report
extens
deposit
ecm
protein
occur
includ
collagen
elastin
fibronectin
start
day
instil
induct
asma
marker
fibroblast
activ
also
evid
day
onward
suggest
fibrosi
began
develop
earli
day
instil
model
importantli
compar
amount
total
latent
activ
detect
balf
instil
studi
studi
sime
colleagu
suggest
fibrot
tissu
like
deposit
lung
tissu
day
instil
treatment
began
new
vitro
data
show
induc
fibrot
respons
includ
express
asma
earli
hour
treatment
hand
significantli
reduc
fibrot
respons
even
cell
pretreat
hour
figur
base
data
conclud
block
lung
fibrosi
least
part
resolv
establish
fibrosi
block
progress
fibrosi
tgfb
play
critic
role
develop
fibrosi
posit
feedback
loop
describ
elsewher
matsuo
colleagu
report
upon
unilater
ureter
obstruct
transgen
mice
show
increas
number
interstiti
myofibroblast
higher
concentr
mrna
seo
colleagu
show
knockout
gene
significantli
differ
alonetr
group
p
n
suppress
express
high
glucoseinduc
mrna
wherea
recombin
restor
induc
high
glucos
knockout
mesangi
cell
furthermor
show
recombin
protein
stimul
tgfb
promot
activ
induct
fibronectin
collagen
recombin
abrog
receptor
inhibitor
antitgfb
antibodi
togeth
data
strongli
suggest
posit
regul
gene
express
present
studi
intranas
instil
control
viru
induc
endogen
well
express
murin
lung
suggest
induct
caus
adenoviru
although
precis
mechan
wherebi
induc
gene
express
unclear
data
suggest
may
involv
complet
block
induct
result
support
notion
posit
feedback
loop
data
also
suggest
block
lung
fibrosi
mice
least
part
break
posit
feedback
loop
myofibroblast
major
produc
ecm
therefor
contribut
importantli
develop
fibrosi
upon
resolut
normal
wound
heal
myofibroblast
undergo
apoptosi
dysregul
apoptosi
therefor
lead
impair
wound
heal
fibrosi
prolong
activ
myofibroblast
mechan
regul
apoptosi
myofibroblast
larg
unknown
present
interestingli
plasmin
report
induc
apoptosi
wherea
protect
myo
fibroblast
apoptosi
induc
differ
stimuli
densiti
myofibroblast
greater
mice
lower
knockout
mice
upon
fibrot
stimul
suggest
may
promot
fibrosi
protect
myofibroblast
apoptosi
studi
increas
express
asma
marker
myofibroblast
murin
lung
human
lung
fibroblast
wherea
suppress
express
asma
vivo
vitro
data
suggest
anoth
potenti
mechan
wherebi
block
lung
fibrosi
induc
apoptosi
myofibroblast
notion
support
flow
cytometri
data
show
induc
apoptosi
naiv
fibroblast
myofibroblast
fibroblast
moreov
flow
cytometri
data
indic
myofibroblast
sensit
apoptosi
naiv
fibroblast
myofibroblast
major
produc
ecm
produc
much
ecm
naiv
fibroblast
myofibroblast
deriv
differ
type
cell
addit
resid
fibroblast
drug
target
myofibroblast
demonstr
better
therapeut
potenti
drug
target
naiv
fibroblast
data
suggest
promis
antifibrot
agent
nonetheless
whether
select
vivo
unknown
mechan
underli
select
investig
warrant
result
studi
aid
develop
effect
antifibrot
drug
differ
hypothes
propos
elucid
mechan
wherebi
protect
cell
apoptosi
one
potenti
mechan
involv
inhibit
activ
directli
bind
protein
studi
without
slightli
significantli
increas
activ
although
underli
mechan
unknown
result
suggest
induc
apoptosi
myo
fibroblast
part
activ
pathway
horowitz
colleagu
show
addit
bind
inhibit
activ
plasminogen
plasmin
induc
apoptosi
fibroblast
associ
pericellular
fibronectin
proteolysi
also
show
protect
fibroblast
apoptosi
induc
plasminogen
plasmin
suggest
protect
fibroblast
apoptosi
inhibit
activ
plasminogen
although
measur
activ
plasmin
data
show
treatment
restor
increas
activ
upa
tpa
mice
cultur
human
lung
fibroblast
suggest
induct
myo
fibroblast
apoptosi
may
result
increas
plasmin
activ
master
control
apoptosi
show
first
time
best
knowledg
express
increas
human
lung
fibroblast
without
treatment
alon
exert
signific
effect
express
slightli
reduc
express
data
suggest
activ
involv
apoptosi
human
lung
fibroblast
although
mechan
underli
activ
pathway
remain
unclear
result
consist
data
report
investig
indic
activ
associ
apoptosi
fibroblast
induc
gallic
acid
silica
also
shown
prevent
apoptosi
lung
injuri
davi
colleagu
show
bleomycin
induc
apoptosi
macrophag
lung
injuri
null
mice
heterozyg
wildtyp
mice
ghosh
colleagu
also
report
knockdown
gene
epitheli
cell
surfact
protein
cexpress
cell
use
dominantneg
techniqu
enhanc
sensit
mice
bleomycininduc
lung
fibrosi
result
suggest
protect
macrophag
lung
epitheli
cell
apoptosi
therebi
lung
injuri
fibrosi
contradictori
effect
apoptosi
lung
injuryfibrosi
explain
divers
function
role
differ
type
cell
develop
fibrosi
myo
fibroblast
major
produc
ecm
induct
myo
fibroblast
apoptosi
expect
attenu
fibrosi
progress
nonetheless
whether
induc
apoptosi
lung
myo
fibroblast
vivo
whether
induct
apoptosi
myo
fibroblast
underli
protect
effect
remain
explor
final
point
perform
multipl
function
involv
pathogenesi
variou
diseas
includ
thrombosi
arthrosclerosi
cancer
fibrosi
therefor
develop
specif
inhibitor
major
focu
mani
studi
sever
strategi
involv
inhibitori
antibodi
mutant
protein
small
interf
rna
propos
inhibit
activ
treatment
diseas
howev
applic
larg
molecul
clinic
set
limit
potenti
deliveri
problem
small
molecul
inhibitor
offer
great
therapeut
potenti
deliv
easili
bodi
oral
effect
sever
small
molecul
inhibitor
prove
effect
treatment
thrombosi
major
area
interest
inhibitor
research
whether
demonstrate
therapeut
potenti
lung
fibrot
diseas
remain
unclear
studi
show
first
time
best
knowledg
dose
mgkgday
day
dose
much
lower
mgkgday
week
use
previou
toxic
studi
shown
caus
obviou
toxic
almost
complet
block
lung
fibrosi
data
suggest
rel
safe
potent
antifibrot
agent
promis
therapeut
potenti
lung
fibrot
diseas
author
disclosur
none
author
financi
relationship
commerci
entiti
interest
subject
manuscript
